PMC:7408073 / 77708-77926 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T445","span":{"begin":19,"end":25},"obj":"Body_part"}],"attributes":[{"id":"A445","pred":"fma_id","subj":"T445","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T146","span":{"begin":19,"end":25},"obj":"Body_part"}],"attributes":[{"id":"A146","pred":"uberon_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2738","span":{"begin":136,"end":140},"obj":"Gene"},{"id":"2753","span":{"begin":34,"end":42},"obj":"Species"},{"id":"2789","span":{"begin":11,"end":33},"obj":"Disease"},{"id":"2790","span":{"begin":64,"end":86},"obj":"Disease"}],"attributes":[{"id":"A2738","pred":"tao:has_database_id","subj":"2738","obj":"Gene:59272"},{"id":"A2753","pred":"tao:has_database_id","subj":"2753","obj":"Tax:9606"},{"id":"A2789","pred":"tao:has_database_id","subj":"2789","obj":"MESH:D051436"},{"id":"A2790","pred":"tao:has_database_id","subj":"2790","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T398","span":{"begin":11,"end":33},"obj":"Disease"},{"id":"T399","span":{"begin":19,"end":33},"obj":"Disease"},{"id":"T401","span":{"begin":64,"end":86},"obj":"Disease"}],"attributes":[{"id":"A398","pred":"mondo_id","subj":"T398","obj":"http://purl.obolibrary.org/obo/MONDO_0005300"},{"id":"A399","pred":"mondo_id","subj":"T399","obj":"http://purl.obolibrary.org/obo/MONDO_0001343"},{"id":"A400","pred":"mondo_id","subj":"T399","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A401","pred":"mondo_id","subj":"T401","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T936","span":{"begin":19,"end":25},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T937","span":{"begin":19,"end":25},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T938","span":{"begin":19,"end":25},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T939","span":{"begin":51,"end":52},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T940","span":{"begin":98,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T941","span":{"begin":141,"end":149},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T31895","span":{"begin":154,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A69235","pred":"chebi_id","subj":"T31895","obj":"http://purl.obolibrary.org/obo/CHEBI_27363"},{"id":"A53620","pred":"chebi_id","subj":"T31895","obj":"http://purl.obolibrary.org/obo/CHEBI_30185"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T381","span":{"begin":0,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T118","span":{"begin":11,"end":33},"obj":"Phenotype"},{"id":"T119","span":{"begin":64,"end":86},"obj":"Phenotype"}],"attributes":[{"id":"A118","pred":"hp_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/HP_0012622"},{"id":"A119","pred":"hp_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}

{"project":"2_test","denotations":[{"id":"32708755-25813276-20678941","span":{"begin":211,"end":213},"obj":"25813276"}],"text":"Indeed, in chronic kidney disease patients without a history of cardiovascular disease, there was a significant decrease in circulating ACE2 activity and zinc levels when compared with healthy control subjects [96,97]."}